Tirzepatide (Mounjaro) Weight Loss Program in Tampa & Online
Metabolic health, properly supervised.
Tirzepatide (Mounjaro®) activates the GLP-1 and GIP receptors simultaneously — a dual mechanism that triggers insulin release, suppresses glucagon, reduces appetite and increases energy expenditure. In the SURMOUNT-1 trial, participants on a 15 mg weekly dose lost an average of 22.5% of body weight over 72 weeks.
At Roots in Tampa, programs are physician-supervised from the first consultation: labs, a metabolic evaluation and a structured titration plan so your dose increases safely alongside nutrition and movement coaching.
Book a weight-loss consultation to find out which option fits you.
Read more about GLP-1 weight loss in the Roots Journal: Semaglutide vs. Tirzepatide in Tampa: Which GLP-1 Weight Loss Program Is Right for You?
Semaglutide
Semaglutide (Wegovy®) is FDA-approved for chronic weight management in adults. In the STEP 1 trial, weekly subcutaneous Semaglutide produced an average weight loss of 14.9%, with 32% of participants losing 20% or more of their initial body weight. At Roots, Semaglutide is an alternative to Tirzepatide — recommended based on your clinical history and labs.
- Weekly subcutaneous injection
- Reduced appetite and food cravings
- Improved glycemic control
- Supervised titration by your provider
- Paired with nutrition and movement coaching
- Regular check-ins to adjust the plan
What Is Medical Weight Loss?
Medical weight loss treats excess weight as a physiological problem — not a willpower failure. Appetite, insulin signaling and energy expenditure are regulated by hormones and metabolic pathways, which is why physician-supervised GLP-1 medications succeed where repeated dieting has not. In Tampa, Roots offers structured programs starting with a metabolic evaluation and lab review, so medication is prescribed based on your biology, not a questionnaire.
Our programs center on Tirzepatide and Semaglutide — both once-weekly subcutaneous injections. Your dose starts low and is titrated upward under supervision. Nutrition and movement coaching are built into every program, and check-ins adjust the plan as your body responds.
What Results Can I Expect From GLP-1 Weight Loss?
In the SURMOUNT-1 trial, adults on 15 mg weekly Tirzepatide lost an average of 22.5% of body weight over 72 weeks — roughly 50 lbs for a 220-lb starting weight. In the STEP 1 trial, weekly Semaglutide produced an average loss of 14.9%, with 32% of participants losing ≥20% of body weight. These are trial averages under controlled conditions; individual results vary with dose, adherence, baseline metabolic health and lifestyle factors.
The timeline is gradual by design. Most patients see steady change over the first three to six months rather than a dramatic drop early on. Slower, supervised titration keeps side effects manageable and results sustainable. Your provider tracks your response at check-ins and adjusts the plan — weight regain is common when treatment stops, so long-term strategy is part of the conversation from the start.
What Does the Published Research Show?
According to the New England Journal of Medicine, the SURMOUNT-1 trial (Jastreboff et al., 2022) followed 2,539 adults with obesity or overweight, without diabetes, for 72 weeks. Participants assigned to 15 mg weekly Tirzepatide lost an average of 20.9% of their body weight, compared with 3.1% on placebo — 22.5% among those who stayed on treatment — and 57% of them lost at least 20% of their body weight, compared with 3% on placebo.
Also published in the New England Journal of Medicine, the STEP 1 trial (Wilding et al., 2021) studied 1,961 adults with obesity or overweight, without diabetes, over 68 weeks. Weekly Semaglutide 2.4 mg produced an average weight loss of 14.9%, compared with 2.4% on placebo, and 86.4% of participants lost at least 5% of their body weight, compared with 31.5% on placebo.
What happens after stopping matters too. In the SURMOUNT-4 trial, published in JAMA (Aronne et al., 2024), adults who lost weight during 36 weeks on Tirzepatide and were then switched to placebo regained 14% of their body weight over the following 52 weeks, while those who continued treatment lost a further 5.5%. That is why every Roots plan addresses maintenance from the first visit, not just the starting dose.
How Does the Roots Weight Loss Program Work?
The program begins with a consultation and comprehensive labs: metabolic panel, thyroid, hormones, liver markers and baseline measurements. Those results determine which medication fits you, what starting dose is safe and what underlying factors — hormonal imbalance, thyroid dysfunction, insulin resistance — may be compounding the picture. Medication alone is rarely the whole answer.
Check-ins track your response, adjust dosing and review labs at regular intervals. A body composition scan at Roots confirms the plan is reducing fat while protecting muscle — a distinction the scale alone cannot show. Nutrition and movement coaching are included throughout, designed to work alongside the medication rather than as a separate program you maintain on your own.
Medical Weight Loss for Tampa Bay Patients
Roots sits at 1120 E Kennedy Blvd in Channelside, minutes from Downtown, Harbour Island, Davis Islands and South Tampa, and patients come to us from across Tampa Bay — Brandon, Westchase, Riverview and St. Petersburg. Check-ins happen in person at the Channelside clinic, and the program is also available online.
Tampa's climate is part of the plan. Summers here are long, hot and humid, and the most common GLP-1 side effects — nausea, vomiting and diarrhea — can make dehydration more likely. The FDA prescribing information for both Mounjaro® and Wegovy® warns of acute kidney injury in patients who become dehydrated from these gastrointestinal side effects, so your provider builds hydration guidance into your plan, especially through the summer months.
The year-round weather also makes movement easier to keep up. An early walk along Bayshore Boulevard or the Tampa Riverwalk counts toward the activity coaching that runs alongside your medication — which matters when the goal is losing fat while protecting muscle.
Medical weight-loss programs require a consultation and provider review of your health history. Results vary and are not guaranteed.
What is Tirzepatide?
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, used in the treatment of obesity, type 2 diabetes and non-alcoholic fatty liver disease.
How is it administered?
Tirzepatide is injected into the subcutaneous tissue once weekly, with or without meals.
How does it work?
It triggers insulin release and blocks glucagon, the hormone that raises blood sugar. It also acts on chemicals in the brain that decrease food intake and increase energy expenditure.
Are there other benefits?
Its effect on blood sugar also supports heart health and improves liver health by reducing liver fat.
Are there side effects?
Side effects may include nausea, vomiting, diarrhea and constipation. Discuss the full side-effect profile with your provider.
Am I a candidate for medical weight loss?
The way to find out is a consultation. We review your health history, current medications and goals, and order lab work before recommending anything — candidacy is a clinical decision, not a questionnaire checkbox. Medical weight loss generally suits adults who have not reached their goals through diet and exercise alone, or who want medication-based support alongside nutrition and movement coaching. Certain conditions and medications affect which options are safe for you, and your provider will tell you plainly if medication is not the right fit.
What medications do you use for weight loss?
Our programs center on Tirzepatide and Semaglutide — both injected subcutaneously once weekly. Tirzepatide activates the GLP-1 and GIP receptors; Semaglutide is a GLP-1 analog, FDA-approved for weight management in adults. Which one suits you depends on your history, labs and goals, and your provider recommends the option at your consultation. Dosing always starts low and is titrated upward under supervision rather than jumped to a target dose.
How is this different from a diet program?
A diet program hands you a meal plan and hopes for the best. Medical weight loss treats excess weight as a physiological problem and works on the biology behind it. You start with a metabolic evaluation and lab work, receive prescription medication where appropriate — something no diet program can offer — and are supervised by a medical provider who adjusts your dose at check-ins. Nutrition and movement coaching are built into the plan, and labs are rechecked so the protocol protects muscle while reducing fat.
Is medical weight loss covered by insurance?
Roots is a cash-pay practice — most GLP-1 medications are not covered by standard insurance here. We can provide an itemized superbill for FSA/HSA reimbursement. Some patients have success submitting to insurance on their own; outcomes vary by plan.
Related reading
Thriving from the inside out.